Answers are grounded in this paper and cite their sources.
Thiamine deficiency encompasses a broad spectrum of neurological disorders, including dry beriberi, Wernicke encephalopathy, and Korsakoff syndrome. Although traditionally described as distinct entities, these conditions frequently overlap and may represent different manifestations of the same underlying metabolic disorder. We report two cases illustrating this clinical continuum. A 76-year-old woman with chronic alcohol consumption, nutritional vulnerability, and precarious living conditions presented with altered mental status, painful lower-limb weakness, paresthesia, areflexia, and impaired ambulation. Associated nystagmus and dysmetria suggested concomitant central nervous system involvement. Empirical high-dose intravenous thiamine resulted in improvement of neurological symptoms and partial recovery of mobility, supporting a diagnosis of probable dry beriberi with overlapping features of Wernicke encephalopathy. A 51-year-old woman with HIV infection, chronic alcohol consumption, and approximately five weeks of minimal food intake presented with confusion, severe memory impairment, horizontal nystagmus, and gait ataxia, fulfilling all four Caine criteria for Wernicke encephalopathy. Despite improvement in ocular abnormalities and gait following intravenous thiamine administration and correction of hypomagnesemia, marked anterograde amnesia and confabulation persisted, suggesting progression toward Korsakoff syndrome. Brain magnetic resonance imaging showed no characteristic abnormalities in either patient, and pretreatment biochemical confirmation of thiamine deficiency was unavailable. These cases highlight the heterogeneous and overlapping manifestations of thiamine deficiency disorders and emphasize that normal neuroimaging or absent laboratory confirmation should not delay treatment. Early recognition, prompt parenteral thiamine administration, correction of associated nutritional deficiencies, and longitudinal cognitive assessment are essential to reduce the risk of persistent neurological disability.
No takes yet. Share an insight, caveat, or question.
Queirós et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: